Risk of oxalate nephropathy with the use of cyanide antidote hydroxocobalamin in critically ill burn patients.
Legrand M, Michel T, Daudon M, Benyamina M, Ferry A, Soussi S, Maurel V, Chaussard M, Chaouat M, Mimoun M, Verine J, Mallet V, Mebazaa A; PRONOBURN Study Group.
Legrand M, et al. Among authors: daudon m.
Intensive Care Med. 2016 Jun;42(6):1080-1. doi: 10.1007/s00134-016-4252-4. Epub 2016 Feb 18.
Intensive Care Med. 2016.
PMID: 26891675
No abstract available.